- We recently attended Q&M Dental Group (SGX:QC7)’s post-results briefing.
- To recap, Q&M Dental reported a headline net loss of S$2.2m in 4Q22, which was below our and market expectations. The variance was largely due to decrease in PCR testing revenue, as well as write-off of about S$5m relating to its COVID-19 related consumables.
- - Read this at SGinvestors.io -
- We cut our FY23-24E earnings per share (EPS) foreacast for Q&M Dental by 15- 16% on slower-than-expected dental business growth and higher opex. Maintain HOLD with a lower target price of S$0.37, based on 22x FY23E P/E.
Room for margins to improve in existing outlets
- - Read this at SGinvestors.io -
- Amid the current inflationary environment, Q&M Dental faces headwinds such as increased manpower and occupancy costs, as well as a shortage of trained nurses.
- Q&M Dental's management articulated that it will now focus on improving the utilisation and productivity of existing clinics (for eg, adding more dental chairs) to expand margins instead of network expansion going forward.
Investment in data-centric AI treatment
- Read more at SGinvestors.io.
